Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Prostatic Neoplasms 3Neoplasms 3Breast Neoplasms 3Pain 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Urinary Incontinence, Stress 1Urinary Incontinence 1Sleep Initiation and Maintenance Disorders 1Postoperative Urinary Retention (POUR) 1Postoperative Nausea and Vomiting 1Postoperative Complications 1PGS 1Opioid-Induced Constipation 1Neuropathy, Painful 1Neuralgia 1Multiple Endocrine Neoplasia Type 1 1Low Anterior Resection Syndrome 1Fatigue 1Depression 1Cancer Pain 1Anxiety Disorders 1Agnosia 1

Interventions

pembrolizumab 243Carboplatin 211Pemetrexed 177Cisplatin 131Paclitaxel 113Nivolumab 101Docetaxel 87osimertinib 85durvalumab 78Specimen Handling 56atezolizumab 55Gemcitabine 52Drug Therapy 52Magnetic Resonance Spectroscopy 50Radiosurgery 48Radiotherapy 47Ipilimumab 41130-nm albumin-bound paclitaxel 39cemiplimab 38Bevacizumab 34Cetuximab 30tislelizumab 29amivantamab 22Taxes 22Platinum Compounds 20Blood Specimen Collection 20Immunotherapy 18Immune Checkpoint Inhibitors 18Radiation 17Erlotinib Hydrochloride 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoma, Non-Small-Cell Lung × Electroacupuncture × 1 year × Clear all
NCT07239661 2025-11-20

Electroacupuncture Combined With PD-1 Inhibitor for ECOG2 Advanced NSCLC

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

Phase NA Recruiting
120 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07086300 2025-07-25

Electroacupuncture Combined With PD-1 Inhibitor for Elderly Patients With Advanced NSCLC

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

Phase NA Recruiting
120 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡